Contract 75N93020C00020
Crestone, Inc. · Department Of Health And Human Services · September 23, 2021
Crestone, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 23, 2021 for $2.09 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Boulder, CO. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses cost-plus contract pricing. The most recent modification was on January 7, 2026. If all options are exercised, the contract could reach $25.50 million.
Contract details
- PIID
- 75N93020C00020
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Boulder, CO
- First action
- September 23, 2021
- Latest action
- January 7, 2026
Description
TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.
Modification timeline
-
January 7, 2026Mod P00014 · Funding Only Action$20.48M
-
December 23, 2025Mod P00013 · Other Administrative ActionDEVELOPMENT OF THERAPEUTIC PRODUCTS FOR ANTIBIOTIC RESISTANT BACTERIA$18.53M
-
September 4, 2025Mod P00012 · Funding Only ActionTO DEOBLIGATE FY 2020 5TH YEAR FUNDS ON LINE 1. TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$18.53M
-
September 29, 2022Mod P00006 · Funding Only Action$13.31M
-
September 23, 2021Mod P00003 · Other Administrative Action$3.72M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $77.58M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $8.41M |
| Technical Resources International, Inc. | Department Of Health And Human Services | July 2, 2026 | $39.32M |
| Consolidated Safety Services Incorporated | Department Of Health And Human Services | July 2, 2026 | $465.3K |
| University Of Mississippi Medical Center | Department Of Health And Human Services | July 2, 2026 | $0 |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $10.12M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93020C00020?
Contract 75N93020C00020 is a federal contract awarded to Crestone, Inc. by Department Of Health And Human Services on September 23, 2021 for $2.09 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 4 times since the base award.
Who won contract 75N93020C00020?
Crestone, Inc. won contract 75N93020C00020 from Department Of Health And Human Services.
How much is contract 75N93020C00020 worth?
Contract 75N93020C00020 has obligated $2.09 million to date, with a total potential value of $25.50 million if all options are exercised.